Transaction in Own Shares 23 July, 2025 • • • • • • • • • • • • • • • • Shell plc (the ‘Company') announces that on 23 July, 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchase Number of Shares purchased Highest price paid Lowest price paid Volume weighted average price paid per share Venue Currency 23/07/2025 644,581 £26.5500 £26.3250 £26.4670 LSE GBP 23/07/2025 121,396 £26.5500 £26.3250 £26.4685 Chi-X (CXE) GBP 23/07/2025 76,023 £26.5500 £26.3250 £26.4709 BATS (BXE) GBP 23/07/2025 479,638 €30.7950 €30.4400 …

Tesla is expected to report a second straight quarter of declining revenue in its earnings report after the bell on Wednesday. Elon Musk's automaker has been ceding market share to companies with more affordable EVs.

Alphabet is set to report its second-quarter earnings after the bell Wednesday. Wall Street expects the company to post double-digit revenue growth, according to LSEG estimates.

PHILADELPHIA--(BUSINESS WIRE)--Comcast's Xfinity Unveils StreamStore: A Smarter, Simpler Way to Discover, Manage and Enjoy Entertainment.

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP reminds investors of the upcoming September 12, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Biohaven Ltd. (“Biohaven” or the “Company”) (NYSE: BHVN) securities between March 24, 2023 and May 14, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR BIOHAVEN INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOV.

LOS ANGELES , July 23, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS) have opportunity to lead the securities fraud class action lawsuit.

LOS ANGELES , July 23, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Tempus AI, Inc. ("Tempus" or the "Company") (NASDAQ: TEM). IF YOU SUFFERED A LOSS ON YOUR TEMPUS INVESTMENTS, CLICK HERE BEFORE AUGUST 12, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?

BENSALEM, Pa. , July 23, 2025 /PRNewswire/ -- The Law Offices of Howard G.

BENSALEM, Pa. , July 23, 2025 /PRNewswire/ -- The Law Offices of Howard G.

PORTLAND, Maine, July 23, 2025 (GLOBE NEWSWIRE) -- Northeast Bank (the “Bank”) (NASDAQ: NBN), a Maine-based bank, announced today it will release its fiscal 2025 fourth quarter earnings results on Monday, July 28, 2025. Following the release, the Bank will host a conference call with a simultaneous webcast at 10:00 a.m. ET on Thursday, July 31, 2025. The conference call will be hosted by Rick Wayne, President and Chief Executive Officer, Richard Cohen, Chief Financial Officer, and Pat Dignan, Chief Operating Officer.

BENSALEM, Pa. , July 23, 2025 /PRNewswire/ -- The Law Offices of Howard G.

MILWAUKEE , July 23, 2025 /PRNewswire/ -- WEC Energy Group Inc. (NYSE: WEC) will issue its 2025 second-quarter earnings news release before the stock market opens Wednesday, July 30. A conference call for investors and security analysts is scheduled for the same day at 1 p.m.

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) securities between November 7, 2024 and July 8, 2025, inclusive (the “Class Period”). RxSight investors have until September 22, 2025 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN RXSIGHT, INC. (RXST), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICI.

Prosperity Bancshares remains a quality operator with a growing 3.2% dividend yield and a strategic, accretive acquisition expanding its Texas footprint. Q2 results showed solid net interest margin and controlled expenses, with earnings in line despite a slight revenue miss and mixed loan/deposit trends. Asset quality is strong, with minimal charge-offs, no provision for credit losses, and improving return metrics and efficiency ratios versus peers.

Upgrading European Wax Center (EWCZ) from 'hold' to a soft 'buy' due to improved clarity on future growth and robust cash flows. Despite a projected net decline in locations for 2025, management expects a return to unit growth and modest same-store sales increases next year. Profitability metrics like adjusted net profit and operating cash flow have improved, while the stock still trades at attractive low multiples.

EXEL investors eye Cabometyx sales and zanzalintinib trial results ahead of Q2 earnings release on July 28.

Reblozyl sales surged 35% in Q1 for BMY, but a failed phase III study clouds expansion plans amid stiff anemia drug competition.

Pre-Markets in Green Amid Trade Deal With Japan.

GD Q2 earnings beat estimates and rise 14.7% year over year. It also witnesses surging backlog, driven by strong Marine, Tech and Aerospace gains.

The U.K.'s Competition and Markets Authority (CMA) announced on Wednesday a proposal that would give Apple and Google's mobile platforms “strategic market status” — a designation that allows the regulator to create rules that could change how their app stores operate and how their mobile software works.